Barely Significant
← all phrases

“showed a trend”

53,323 sentences · 53,323 papers · 65,371 search hits before verification

In the literature

showed a trendp = .0591.2× alpha
In this more complex model, the main effect of APOE showed a trend (F(1,68) = 3.68, p = .059, η p 2 = .051), with higher scores for ε4 carriers compared to non-carriers, and there was also a trend for an interaction between APOE and age, with ε4 carriers scoring higher than non-carriers at younger ages and lower at older ages (F(1,68) = 3.60, p = .062, η p 2 = .050). 3.3 Discussion APOE genotype was deemed a possible predictor of individual differences since in adulthood in DS, it increases the risk of AD by a hazard ratio of 1.8 and there is evidence that the genotype also influences early brain development ( Dean et al., 2014 ; Prasher et al., 2008 ).
showed a trendp = 0.0591.2× alpha
Given that most adult patients were comparable with the controls in age, and the pediatric subgroup (age ⩽ 16 years; 6/12) showed a trend of higher positive rate in 7T MRI post-processing than adult patients (4/23; Fisher’s exact test, p = 0.059), we think the inclusion of pediatric patients would not significantly impact the results.
showed a trendP = .0591.2× alpha
For heart failure hospitalization, the multiple-lesion PCI group showed a trend towards increased risk (adjusted sHR: 1.54; 95% CI: 0.98-2.42; P = .059), while the single-lesion PCI group had significantly higher risk (adjusted sHR: 1.61; 95% CI: 1.01-2.56; P = .042).
showed a trendp = 0.05911.2× alpha
In LN18 cells 213 Bi-anti-EGFR-MAb treatment induced also an increase, which showed a trend towards statistical significance (p = 0.0591): analysis of cell culture medium revealed a LDH activity of 31.1 ± 5.4 ng/ml and 46.6 ± 7,3 ng/ml for controls and 213 Bi-anti-EGFR-MAb treated cells, respectively.
showed a trendp = 0.05931.2× alpha
Calcium accumulation in channelled constructs showed a trend towards a significant increase, as compared to solid constructs, at 4 weeks post-implantation (4.37±0.61 vs. 3.27±0.33%ww, p = 0.0593), with this difference becoming significant at 8 weeks post-implantation (7.97±1.15 vs. 5.12±0.53%ww, p <0.0001).
showed a trendP = 0.05951.2× alpha
After adjusting the covariates, age, sex, and comorbidities in the multivariate analysis, the duration of treatment was a significant factor that increased the risk of developing renal events (> 1 to ≤ 3 years, risk ratio [RR] 1.2, 95% CI 1.12–1.54; P = 0.0007; > 3 to ≤ 5 years, RR: 1.38, 95% CI 1.04–1.84; P = 0.0254) while consistency of use was not statistically significant but showed a trend towards increasing the risk of developing renal events (RR: 1.24, 95% CI 0.99–1.55; P = 0.0595) (Table 3 ).